EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, XBIO: Xenetic Biosciences Inc

20 Oct 25 14:37
LAST:

4.220

CHANGE:
 0.05		OPEN:
4.220		HIGH:
4.510		ASK:
1.560		VOLUME:
51.0K
CHG(%):
1.17		PREV:
4.270		LOW:
4.050		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Oct 254.2204.5104.0504.22051.0K
17 Oct 254.2804.4304.1504.21080.7K
16 Oct 254.8104.8904.2604.390136.5K
15 Oct 255.1205.2804.5664.810188.8K
14 Oct 255.2305.9004.9455.070259.4K
13 Oct 256.4306.5155.3705.370373.7K
10 Oct 258.8708.8705.8506.330998.6K
09 Oct 259.21010.2408.5109.460768.9K
08 Oct 2511.70013.9309.34010.36047.43M
07 Oct 253.2604.7283.2404.290290.4K

COMPANY PROFILE

Name:Xenetic Biosciences Inc
About:Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. The company's proprietary DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression, pancreatic ductal adenocarcinoma, colorectal carcinoma, and other gastrointestinal cancer. Its product pipeline includes XBIO-015 for treating pancreatic carcinoma and solid tumors; and XBIO-020 for treating solid tumors. The company also has partnered with biotechnology and pharmaceutical companies to develop its proprietary drug delivery platform, PolyXen, which as an enabling platform technology for protein and peptide drug delivery. It has collaboration agreements with Belgian Volition SARL Limited to develop NETs-targeted adoptive cell therapies for the treatment of cancer, as well as PJSC Pharmsynthez and Serum Institute of India to develop and launch ErepoXen for the treatment of anemia in chronic kidney disease patients; sublicensing agreement with Takeda Pharmaceutical Co. Ltd; exclusive sublicense agreement with CLS Therapeutics Ltd to develop DNase technology for the treatment of immunotherapies. The company offers under XDNASE, XCART, OncoHist, PolyXen, ErepoXen, and ImuXen trandemarks. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:945 Concord Street, Framingham, MA, United States, 01701
Website:https://www.xeneticbio.com
CUSIP:984015107
CIK:0001534525
ISIN:US9840155033
FIGI:BBG0028WJXC0
LEI:5493002WV0KYX8JXAH52

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:4.547.6%
MA10:5.8538.6%
MA20:4.537.3%
MA50:3.6216.6%
MA100:3.4920.8%
MA200:3.4622.0%
STO9:0.10 
STO14:10.34 
RSI14:53.98
WPR14:-84.57 
MTM14:1.12
ROC14:0.36 
ATR:1.56 
Week High:6.5254.4%
Week Low:4.054.2%
Month High:13.93230.1%
Month Low:2.8122.0%
Year High:13.93230.1%
Year Low:2.2091.8%

RECENT SPLITS

Date Ratio
15 May 20231-10
25 Jun 20191-12